# Risks and Management of Central Serous Chorioretinopathy in a Middle-Aged Female

**Authors:** Reshma Annam, Pravallika Padyala, Preethi Annam, Sailaja Nandennagari, Krupavaram Bethala

PMC · DOI: 10.7759/cureus.51325 · Cureus · 2023-12-30

## TL;DR

This case report describes a rare instance of central serous chorioretinopathy in a middle-aged woman, highlighting unusual aspects of the condition.

## Contribution

The paper presents a unique case of CSC in a female, where typical risk factors are absent, challenging common assumptions.

## Key findings

- A 33-year-old female was diagnosed with CSC and showed remission after four months.
- CSC is typically more common in males, making this case unusual.
- The patient's condition lacked typical risk factors, raising questions about CSC etiology.

## Abstract

Central serous chorioretinopathy (CSC) is the buildup of fluid in the posterior pole distorting the vision resulting from either neurosensory or retinal pigment epithelial detachment. This is a case report of a 33-year-old female complaining of cloudiness in the left eye who was subsequently diagnosed with CSC using optical coherence tomography (OCT). Remission was observed in four months, possibly from ocular drop treatment or spontaneous. Our case report is unique as the incidence of CSC is more common in males, almost six times higher than in females. Also, the etiology of CSC in this case report is questionable because all the risks are excluded from our patient history.

## Linked entities

- **Diseases:** Central serous chorioretinopathy (MONDO:0018616)

## Full-text entities

- **Genes:** CFH (complement factor H) [NCBI Gene 3075] {aka AHUS1, AMBP1, ARMD4, ARMS1, CFHL3, FH}
- **Diseases:** blurred (MESH:D014786), type A personality behaviors (MESH:D010554), inflammation (MESH:D007249), cell dysfunction (MESH:D002292), autoimmune diseases (MESH:D001327), visual distortions (MESH:D006311), RPE damage (MESH:D012164), neurosensory (MESH:D006319), CSC (MESH:D056833), cloudiness in (MESH:C563262), lack of sleep (MESH:D001259), insomnia (MESH:D007319), Helicobacter pylori infection (MESH:D016481), SRF (MESH:D006949), retinal detachment (MESH:D012163), hypertension (MESH:D006973), diabetes mellitus (MESH:D003920)
- **Chemicals:** Lutein (MESH:D014975), mifepristone (MESH:D015735), Bevacizumab (MESH:D000068258), steroid (MESH:D013256), MR antagonists (-), testosterone (MESH:D013739), spironolactone (MESH:D013148), eplerenone (MESH:D000077545), vitamin E (MESH:D014810)
- **Species:** Homo sapiens (human, species) [taxon 9606], Helicobacter pylori (species) [taxon 210]
- **Cell lines:** RPE — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_IQ82)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10824147/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10824147/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC10824147/full.md

---
Source: https://tomesphere.com/paper/PMC10824147